Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Book Review
Case Report
Case Series
JISH Reviewers List
Original Article
Pilot Research Projects/Observational Studies
Policy Paper on Homoeopathic Education
Policy Paper on Homoeopathic Education/Research/Clinical Training
Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Book Review
Case Report
Case Series
JISH Reviewers List
Original Article
Pilot Research Projects/Observational Studies
Policy Paper on Homoeopathic Education
Policy Paper on Homoeopathic Education/Research/Clinical Training
Review Article
View/Download PDF

Translate this page into:

Original Article
4 (
); 4-11

The scope of homoeopathy in improving the quality of life in patients with end-stage renal disease: A case series

Department of Homoeopathic Philosophy and Organon, Dr. M.L. Dhawale Memorial Homoeopathic Institute, Palghar, Maharashtra, India
Corresponding author: Dr. Mehvish Haris Dandoti, Department of Homoeopathic Philosophy and Organon, Dr. M.L. Dhawale Memorial Homoeopathic Institute, Palghar, Maharashtra, India.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Dandoti MH, Kapse AR. The scope of homoeopathy in improving the quality of life in patients with end-stage renal disease: A case series. J Intgr Stand Homoeopathy 2021;4(1):4-11.



Lifestyle disorders such as diabetes mellitus, hypertension and cardiovascular diseases eventually affect the kidneys, often causing renal failure. The current gold standard methods for managing renal failure are renal replacement therapy and haemodialysis. Unfortunately, dialysis deteriorates the patient’s quality of life (QOL). Homoeopaths rarely treat cases with such advanced irreversible pathology; the scope of homoeopathy in such cases is, therefore, unclear. We observed the effect of homoeopathy as an adjuvant on the QOL in patients with end-stage renal disease (ESRD). The QOL was assessed using the Marathi version of the Kidney Disease QOL Short Form 1.3 (KDQOL SF version 1.3).

Materials and Methods:

Three Indian patients with ESRD (two men and one woman, individualized ages 38, 50 and 54 years) consented to have their data published. The cases were managed with constitutional homoeopathic remedies in the 50 millesimal (LM) potency as an adjuvant to their current allopathic medications and were observed for 6 months. They were assessed with the Marathi version of the KDQOL SF 1.3 before and after homoeopathic management along with regular haemodialysis.


The patients showed significant improvements in the QOL, especially in the areas of sleep, pain, symptoms and problems, cognitive functioning, emotional well-being and social functioning, as assessed based on the increase in scores in their respective domains.


The results of the observations are promising and in concurrence with homoeopathic philosophy; the benefits of constitutional medicines were seen. All three patients showed an improvement in their QOL. However, studies with larger sample size and randomised controlled trial study design are suggested. Homoeopathic constitutional treatment has a significant impact on the QOL in patients with ESRD.


Quality of life
End-stage renal disease
50 Millesimal


End-stage renal disease (ESRD) is the irreversible deterioration of renal function to an extent that is incompatible with life without renal replacement therapy, either through dialysis or transplant. In such advanced renal pathology, the prevalent management method is haemodialysis. However, the burden of ESRD is on the rise.[1]

While haemodialysis is a lifesaving treatment, it is also known to create problems for patients. In clinical terms, it affects the quality of life (QOL). The WHO defines QOL as an individual’s perception of their position in life in the context of the culture and value systems in which they live as well as in relation to their goals, expectations, standards and concerns. It is a broad concept that is affected in a complex way by the person’s physical health, psychological state, personal beliefs, social relationships and their relationship to salient features of their environment. Assessment of the QOL is important in cases where the primary management comprises haemodialysis. Several studies are available that document the effect of haemodialysis on the QOL.[2,3]

Several reliable tools are available to assess the QOL in patients with ESRD on haemodialysis. The Kidney Disease QOL Short Form 1.3 (KDQOL SF 1.3)[4] is one such tool. The KDQOL SF 1.3 instrument is a self-report measure developed for individuals with kidney disease who are on haemodialysis. The KDQOL SF 1.3 incudes 43 kidney disease targeted items as well as 36 items that provide a generic core and an overall health rating item. This short form differs from the longer version 1.2 by adding a screening about sexual activity.

In haemodialysis, the body’s functioning is mechanically managed on a regular basis to ensure survival. However, as the QOL deteriorates,[5,6] the patient’s routine functioning is inappropriate and below the current standards of health. The patient’s social, emotional and physical spheres are deeply affected. They often develop post-dialysis symptoms such as cramps, hypotension and backache.[2] Emotionally, the patient is often depressed.[7] Social interactions, thinking capacities and intellectual activities reduce as well.[8]

During our initial interactions with patients undergoing haemodialysis when they filled the KDQOL, we noted that despite being aware that haemodialysis was a lifesaving procedure, the patients would describe the experience as ‘torture,’ ‘prison’ and ‘slavery;’ one patient attempted to be positive by stating that haemodialysis was ‘salvation.’ There are various studies linking patients on haemodialysis and poor QOL.[9] There is intense itching due to uraemia.[10,11] Studies show a higher incidence of depression in patients with ESRD, with a trend of increased deaths. There are studies indicating the relationship between QOL and morbidity and mortality.[12] Sleep is another parameter drastically affected in patients undergoing haemodialysis.[13] Muscular atrophy, aches and conditions such as restless leg syndrome are common as well.[14] Patients undergoing dialysis are reported to have a poorer QOL than the general population.[15]

Homoeopathic constitutional remedies are known to work on the ‘whole’[16] individual as mentioned in aphorism 2 and 6 of The Organon of Medicine. Thus, all the aspects of the patient’s well-being: mental, physical and social, are expected to improve; these are part of various domains of QOL. Improved QOL along with increased survival brings the patient closer to the complete definition of health. Several case reports show improvement in patients with chronic renal failure after homoeopathic treatment. Gupta. G, et al has shown the efficacy of homoeopathic medicines in patients undergoing haemodialysis with constitutional as well as organ-specific remedies.[17]

Ali, MK presented a conference paper on the role of homoeopathy in renal disorders.[18] Nikam, A describes several cases of renal failure wherein homoeopathy produced excellent results.[19] The efficacy of individual remedies in patients undergoing haemodialysis for example, China rubra, has also been studied.[20]

In such cases, the scope of a constitutional remedy holds a promise of action at all the above-mentioned levels, especially the LM potency. As the LM potency is the highest available scale of dilution at present, it is often recommended for use in cases with advanced pathology; it also has the least possibility of aggravations and adverse effects on the patients’ vitality.[21]

However, a well-documented study on the QOL on patients of haemodialysis managed with homoeopathy is not readily available. We, therefore, conducted this study to determine all the levels at which homoeopathy works in patients with ESRD undergoing haemodialysis.


Three patients (two men and one woman; ages 38, 50 and 54 years), all Indians, agreed to be included in the study. The cases were managed with constitutional homoeopathic remedies in the 50 millesimal (LM) potency as an adjuvant to their current allopathic medications and were observed for 6 months. They were assessed with the Marathi version of the KDQOL SF 1.3 once before and after homoeopathic management along with regular haemodialysis.[22]


Date of case definition: 08 September 2018

A 38-year-old male, working as a deputy manager in a well-known bank was on haemodialysis for 2 years. At the time of case definition, the patient complained of severe post-dialysis cramps and mild itching of scalp (<sun +++, < warmth +++ and >cold bath). He also had a low mood, very poor socialisation, disinterest in social activity and reduced appetite. He was extremely sad and irritable3+ because of the on-going divorce with his wife. He had insomnia that persisted despite taking sedatives. The patient underwent dialysis thrice a week; his serum creatinine level was 10.1 mg/dL and the BUN level was 57.7 mg/dL, indicative of poor compliance toward dialysis. He also had fluctuation in blood pressure ranging from 180/110 to150/100 mmHg. The patient was diagnosed with ESRD due to hypertensive nephrosclerosis with ischaemic heart disease and depression not otherwise specified.


  • A/f Grief3+

  • Anger, with indignation+++

  • Anger hatred with +++

  • Weeping due to grief+++

  • Loneliness and forsaken lonely feeling+++

  • Dwelling on past disagreeable events +++

  • Brooding+++

  • Contradiction, intolerant of ++

  • Consolation ameliorates of specific people+

  • Desires pungent +++

  • Aversion – milk +++

  • Perspiration – profuse +++

  • In bus vomiting +++ (motion sickness)

  • Headache < sun +++

  • Skin itching < heat+++, <warmth +++, <sun+++ and >cold ++.

Case discussion

The case was understood by his characteristic reaction and ‘anger’ pattern as he was ready to compromise his life by missing the dialysis. He had marked persistent lonely and forsaken feeling since childhood that increased with age. The predominant theme was breaking of relationships. There was extreme disappointment due to the separation from wife, with inability to break free and move on from past relationship and extreme brooding.


The patient’s general level of sadness reduced; he could interact with the people around him. The skin complaint reduced by 70% and the post-dialysis weakness disappeared. He could sleep without sedatives. His blood pressure stabilised at 140/90 mmHg, and serum creatinine level stabilised at 6 mg/dL [Table 1].

Case report 2

Date of case definition: 31 January 2019.

A 50-year-old male patient who had completed the ITI certification but was presently unemployed. He would report to the dialysis centre in a wheelchair. His complaints were vomiting of food particles++ watery in nature, bilateral pedal oedema, decreased appetite, weakness and decreased urine output for 5 months. Vomiting <immediately after eating food++, <after drinking ++, uneasiness with sensation of discomfort. Reserved +++, aversion to company+++ always sitting at the beach. Sleeplessness+++ and restlessness+++ Abusiveness+++ alternating with depressed mood. The complaints of behaviour started after he was cheated by a colleague and lost his job. He was aggravated by loud noise+++, music +++ and if anybody came near him3+. His serum creatinine level was 8.72 mg/dL and BUN level was 87 mg/dL at the time of case definition. He had started dialysis in September 2018.

The patient also had hypertension for the past 5–6 years without regular treatment in the beginning.

Table 1:: Follow up summary
Follow-up criteria
Sleep in hours and initiation General weakness Cramps in legs Mood –depressed/anxious Lower limb oedema Skin itching Bp [220/110] Wt. Changes due to water retention Serum BUN/serum creatinine Prescription
September 6, 2018 >++ Sq Occ. >+ + + Inc. 220/120 mmHg Sq [Aug]
12.1 mg/dL
56.1 mg/dL
9.5 mg/dL
Natrum mur 0/1 weekly three doses
October 11, 2018 N Lasts only 2 h post-dialysis Just after dialysis/for some time >++ <+ >70% >+ [200/100 mmHg] >++ Improved.
51.2 mg/dL
8.3 mg/dL
Natrum mur 0/1 weekly daily dose
January 21, 2019 Improved SQ 0 0 +++ Poor Inc +[220/110 mmHg] 0 52.7 mg/dL
10.17 mg/dL
Natrum mur 0/2 weekly dose
February 11, 19 > ++ Improved 0 0 >20% >20% >+200/100 mmHg 0 52.7 mg/dL
10.17 mg/dL
Natrum mur 0/2 weekly three doses
March 7, 2019 > +++ Improved 0 0 >70% >70% >70% 140/90 mmHg 0 43.7 mg/dL
6 mg/dL
Natrum mur 0/2 daily dose

The patient was diagnosed with ESRD due to hypertensive nephrosclerosis and mood disorder. All this information were obtained through the patient’s wife; he did not utter a single word. The patient avoided eye contact with anyone in the OPD and had an expression of hatred on his face. According to his wife, the patient is constantly in this state and refuses to even get up from his chair.


  • A/F – deceived, from being

  • A/F – grief

  • A/F – loss of job

  • Brooding

  • Company aversion to

  • Music aversion to

  • Desires – Seaside –

  • Sweets – Aversion

  • Fish – Desire

  • Meat – desires.

Case discussion

The case was understood based on the characteristic pattern of response of brooding and intense disappointment. Natrum mur came up as one of the highest in repertorisation. The pattern of break and disappointment in a single relationship is a hallmark of natrum group as per the modern understanding of the natrum group.[23,24] Natrum mur 0/1 was prescribed in one dose weekly for 3 months. The repetition was increased to thrice a week until 6 months consistently.


The patient was initially assessed with the KDQOL SF 1.3 in January 2019, when he consented to participate in the study. The second assessment was performed in July 2019 [Table 2].

Case report 3

Date of case definition: 04 October 2017

The patient was a 54-year-old female, housewife, married for 30 years with four sons and three daughters. She developed weakness +++ and breathlessness+++. She was diagnosed with chronic kidney disease Grade 1 due to chronic glomerulonephritis after her daughter’s marriage in November 2005. In November 2015, she had multiple episodes of generalised tonic clonic seizures. She had disorientation3+, drowsiness3+ and breathlessness+++ <night ++, <lying down and > lying on sides++. She was diagnosed with uraemic encephalopathy. A 2D Echo showed signs of concentric left ventricular hypertrophy; her left ventricular ejection fraction was 45%, indicating diastolic dysfunction. Her serum creatinine level was 9.9 mg/dL. This occurred after she had a dispute with her daughter-in-law; she had to start dialysis twice a week, which relieved her symptoms.

In August 2016, the patient developed breathlessness ++, heaviness of chest++, oliguria+ and abdominal distension++; she was admitted to our hospital and her dialysis increased to thrice a week. She then reported breathlessness <night ++, <lying down and > lying on sides++. These symptoms persisted despite the reduction in fluid overload due to the increased frequency of haemodialysis.

The final diagnosis was ESRD due to chronic tubulointerstitial nephritis and chronic glomerulonephritis with osteoarthritis and left ventricular hypertrophy.


  • A/f loneliness after daughter’s marriage

  • A/f suppressed anger and vexation+++

  • Weeping in anger+++

  • Weeping while talking about sickness

  • Fastidious +++

  • Uric acid diathesis

  • General exhaustion+++

  • P/H/O convulsions due to uraemia

  • Breathlessness +++

  • <night ++<lying down

  • >Lying on sides++

  • Air hunger +++ during breathlessness++

  • Sycosis.

Table 2:: Follow up summary
Follow -up criteria date Sleep [initiation/dur/dist] Appetite Mood Ability to carry out various activities at home [walking] Socialisation [eye
Nausea Vomiting Serum BUN/Creat/urea Prescription
31, 2019
+ + + + + + + Natrum
mur 0/1
once weekly
7, 2019
>75% SQ >+50-75% SQ >+ 0 0 87.7 mg/dL/
8.29 mg/dL
mur 0/1 once weekly
March 4, 2019 to
July 11, 2019
SQ, >++ (reduced duration), relief sustained Improved consistently >++, good >+, progressed to >++ >+, progressed
to >++
0 0 65.9 mg/dL/
7.52 mg/dL to 11.20 mg/dL/
59 mg/dL
Natrum mur 0/1 three doses weekly

The patient was managed between 4 October 2017 and 30 April 2018 where she was partially better until she developed a different state of complete apathy and disinterest in life; seemed to be simply drowned in her sadness which was significantly observed from December 2017.


CT scan brain December 8, 2017 showed fresh infarct in the left thalamocapsular region with subtle periventricular white matter changes and Corticocerebral atrophy.

However, Kali carb was continued for more 6 months from gradual onset of new symptoms from December 2017 until April 2018. The patient agreed to participate in the study and filled the 1st KDQOL SF version 1.3 in the month of April 2018. The patient’s totality was revised on 3 May 2018:

Revised totality

  • Ailments from grief

  • Company desire for

  • Consolation ameliorates

  • Fear of death

  • Indifference, apathy

  • Takes long time to reply

  • Brooding

  • Fastidious

  • Perspiration on face only

  • Aversion to meat.

Case discussion

The final remedy selected was Acid phos 0/1 single dose daily, based on the coexistence of extreme apathy and depression, along with the exhaustion and sleeplessness in night and sleepy during the day.

On 8 May 2018, a neurologist was consulted due to intermittent phases of disorientation and somnambulism for 10–15 days.

The neurologist recommended a 1.5 T MRI B stroke protocol and other investigations and advised to have the patient shifted to a tertiary care centre. Her family refused for investigations or referral to a higher centre; they accepted this as her last phase of life. The probable diagnosis was left middle cerebral artery infarct or small multiple infarcts. The patient also felt that these are her last days and she will not be able to see her youngest son’s marriage.

Understanding of the state: During treatment, the patient developed a peculiar state and had to be treated with a separate remedy after revising the totality.

In this case, loss of expressions was in itself a marked characteristic. Pathak describes in his Materia Medica, ‘Apathetic from unequal struggling with adverse circumstances, mental and physical.’ The mental state is one of sleepiness, brooding, aversion to business, indifference, hopelessness and despair. Correspondingly, in the body, there is weakness, lack of energy and disposition to lie down.[25]


The patient’s post-dialysis weakness reduced, her appetite improved by 70–80%, her socialisation and capacity to sit up were regained and she could eventually walk on her own. She could attend her son’s wedding with ease and comfort [Table 3].

She was assessed on a monthly basis. She was first administered the KDQOL SF 1.3 in May 2018, with a follow-up assessment in October 2018.


Results of the KDQOL SF 1.3 are given in [Table 4].


This study was conducted to find the scope of homoeopathic management on the QOL in patients with ESRD who were undergoing haemodialysis and were assessed with help KDQOL SF 1.3. After going through the results, we derived the following conclusions:

If we compare the scores[26] of each case, significant improvements are seen in the patient scores regarding the subjective conditions: Burden of kidney disease, cognitive function, quality of relationships, sleep, dialysis satisfaction, patient satisfaction, pain, emotional well-being and social and energy fatigue. These are the subjective sensations and emotions felt by the patient and observed by close relatives and acquaintances.

However, the rest of the parameters such as work status and sexual functioning showed no change in the score. Sexual functioning is part of the KDQOL SF 1.3 and hence even though patients have not mentioned anything, it is one of the 12 items of KDQOL SF 1.3.

The social support score improved in cases 1 and 2 but deteriorated in case 3. The physical functioning did not improve; in fact, the score was lower. No change occurred in the parameters of blood urea nitrogen or serum creatinine level as well.

Table 3:: Follow up summary
Follow-up criteria Date Post-dialysis weakness Appetite/stools/urine Socialisation Desire to work Capacity for daily work Pain in legs/ability to walk Sleep Prescription
March 15, 2018 Sq Reduced nil nil No capacity +++/nil Nil in night/sleepy in day Acid phos 0/1 weekly
one dose
May 3, 2018 Sq Sq sq sq sq sq 1–2 h at night/2–3 h awake in day Acid phos 0/1 weekly three doses
June 2, 2018 >20% Improved by 30–40% Improved by 60% Improved 30% >50% 0/started standing on own Improved by 30–40% Daily doses Acid phos 0/1
August 9, 2018 >70–80% Improved 50-60% Improved by 80% Improved by 50% >60% 0/Can walk on her own to dialysis unit from gate of the hospital unit [0.2 km] 4–5 h night/2–3 h in day Daily doses of Acid phos 0/1
Table 4:: Results of the KDQOL SF 1.3 in all patients before and after treatment.
Parameters Case 1 before treatment Case 1 after treatment Case 2 before treatment Case 2 after treatment Case 3 before treatment Case 3 after treatment
Symptoms 36.66 81.25 36.66 81.25 41.67 81.33
Effects of kidney disease 43.75 8.25 43.75 10 18.75 84.35
Burden of kidney disease 18.75 37.5 18.75 37.5 6.25 62.5
Work status 0 0 0 0 0 0
Cognitive function 33.33 66.67 33.33 66.67 33.33 40
Quality of social inter-relationship 26.67 66.67 26.67 75 93.33 86.7
Sexual function 100 83.33 100 83.33 0 100
Sleep 50 65 50 75 22.5 52.5
Social support 0 49.99 0 50 83.33 0
Dialysis staff satisfaction 62.5 100 62.5 100 50 75
Patient satisfaction 66.7 50 66.7 50 66.7 50
Physical function 50 15 50 75 95 35
Role: Physical 100 100 100 100 0 100
Pain 22.5 67.5 22.5 75 10 100
General health 45 45 45 45 20 30
Emotional well-being 20 60 20 80 0 84
Role: Emotional 100 0 100 0 0 100
Social fatigue 50 75 50 75 62.5 100
Energy fatigue 40 65 40 65 0 0

We observed that after the initial infrequent doses, frequent repetition was often required. This can be understood in the light of the patient’s susceptibility, which gradually decreases in the long term as these cases have advanced irreversible structural changes in the kidneys.

The application of the KDQOL SF 1.3 has helped to prove the scope of homoeopathy through an analytical way. However, there are multiple variables since dialysis is a dynamic event in itself and it affects the filling up of questionnaire like changes in fluid extraction may cause hypotension and for that day or week patient is uncomfortable in filling of the questionnaire. One needs to be well versed with the process of haemodialysis in general, to understand the variations it causes to a study. A larger sample size in further studies would prove more useful. An experimental study is obviously more fruitful than a case series. Case series is highlighting that there are significant changes seen through an universally accepted KDQOL SF 1.3. This article is intended to motivate researchers to create a pool of evidence slowly building up on this study where more work can be done eventually, opening the scope of homoeopathy in structurally irreversible and advanced stages. At times, homoeopaths claim to remove dialysis, but this has proved to be impossible and the only scope of homoeopathy is to show qualitative improvement.


The use of homoeopathy as an ancillary therapy in patients with ESRD was found to provide good palliative care. Homoeopathic management through constitutional prescriptions in LM potency was found to significantly improve the QOL in patients with ESRD. This improvement in the QOL was assessed using the KDQOL SF 1.3, where significant improvement in the scores related to several areas was noted.

Declaration of patient consent

Patient’s consent not required as patients identity is not disclosed or compromised.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.


  1. . The Economics of Dialysis in India. 2009 Available from: [Last accessed on 2021 Mar 03]
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , , , . Harrison's Principles of Internal Medicine (16th ed). Ohio, USA: McGraw-Hill Professional Publishing; .
    [Google Scholar]
  3. , , . WHOQOL-Hindi: A Questionnaire for Assessing Quality of Life in Health Care Settings in India. . Available from: [Last accessed on 2020 Nov 03]
    [Google Scholar]
  4. , , , , , , et al. Kidney Disease Quality of Life Short Form (KDQOL SFTM) Version 1.3: A Manual for Use and Scoring. Available from: [Last accessed on 2021 Mar 03]
    [Google Scholar]
  5. . Quality of Life: An Outcomes Perspective. Available from: [Last accessed on 2020 Nov 03]
    [Google Scholar]
  6. , , , , , , et al. Health-related quality of life in end-stage renal disease patients: The effects of starting dialysis in the first year after the transition period. Int Urol Nephrol. 2018;50:1131-42. Available from: [Last accessed on 2021 Mar 03]
    [CrossRef] [PubMed] [Google Scholar]
  7. , . The Effect of Depression and Anxiety on the Performance Status of End-stage Renal Disease Patients Undergoing Hemodialysis. . Available from:;year=2016;volume=27;issue=2;spage=331;epage=334;aulast=Rajan;t=6 [Last accessed on 2021 Mar 03]
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , , , et al. Cognitive function assessment in patients with end-stage renal disease in Nigeria: A single center experience. Ann Afr Med. 2016;15:138-44.
    [CrossRef] [PubMed] [Google Scholar]
  9. , . Factors Affecting Quality of Life in Persons on Hemodialysis. . Available from: [Last accessed on 2021 Mar 03]
    [Google Scholar]
  10. , , , , , . Quality of Life in Patients with Uraemic Xerosis and Pruritus. . Available from: [Last accessed on 2021 Mar 03]
    [Google Scholar]
  11. , , , . Uraemic Pruritus Markedly Affects the Quality of Life and Depressive Symptoms in Haemodialysis Patients with End-stage Renal Disease. . Available from: https://www.uraemicpruritus-markedly-affects-the-quality-of-life-and-depressive-symptoms-in-haemodialysis-patients-with-end-stage-renal-disease.pdf [Last accessed on 2021 Mar 03]
    [Google Scholar]
  12. , , , , , , et al. Morbidity and Mortality in ESRD Patients on Dialysis. Available from:;year=2002;volume=13;issue=4;spage=473;epage=477;aulast=Al [Last accessed on 2020 Nov 03]
    [Google Scholar]
  13. , , , , , , et al. Quality of sleep and health-related quality of life in haemodialysis patients. Nephrol Dial Transplant. 2003;18:126-32. Available from: [Last accessed on 2021 Mar 03]
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , , , et al. Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome. PLoS One. 2011;6:e25180.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , , , et al. Health-related quality of life among dialysis patients on three continents: The dialysis outcomes and practice patterns study. Kidney Int. 2003;64:1903-10.
    [CrossRef] [PubMed] [Google Scholar]
  16. . Organon of Medicine (6th ed). New Delhi: B. Jain Publishers; .
    [Google Scholar]
  17. . A clinical study the role of homoeopathic medicines on chronic renal failure assessed by estimated glomerular filtration rate eGFR. Natl J Homoeopathy. 2015;17:14-8.
    [Google Scholar]
  18. . Scope of Homeopathy in Renal Disorders. Available from: [Last accessed on 2021 Mar 03]
    [Google Scholar]
  19. . Chronic Renal Failure. Available from: [Last accessed on 2020 Nov 03]
    [Google Scholar]
  20. , . Effects of Homoeopathic Dilutions of China Rubra on Intradialytic Symptomatology in Patients Treated with Chronic Haemodialysis. . Available from: [Last accessed on 2021 Mar 03]
    [Google Scholar]
  21. , , , , , . Evaluating the Usefulness of 50 Millesimal Potencies in the Treatment of Chronic Diseases-A Retrospective Study. . Available from:;year=2015;volume=9;issue=2;spage=96;epage=101;aulast=Abarna [Last accessed on 2021 Mar 03]
    [CrossRef] [Google Scholar]
  22. , , , , . Validity of Marathi translated kidney disease quality of life short form (KDQOL-SF) TM. J Evid Based Med Healthc. 2015;2:1. Available from: [Last accessed on 2021 Mar 03]
    [CrossRef] [Google Scholar]
  23. . Portraits of Homoeopathic Medicines Missouri, United States of America: Quality Medical Publishing, Inc.; .
    [Google Scholar]
  24. . Prisma (2nd ed). Haarlem, Netherlands: Emryss BV Publishers; .
    [Google Scholar]
  25. . Concise Materia Medica by S.R. Phatak. . Available from: [Last accessed on 2021 Mar 03]
    [Google Scholar]
  26. , . Kidney Disease Short Form Version 1.3 a Manual for Using and Scoring. . Available from: [Last accessed on 2021 Mar 03]
    [Google Scholar]
Show Sections